[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342800-105":59,"doc-detail-342800-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","racial-disparities-in-initiation-of-chemotherapy-among-breast-cancer-patients-with-discretionary-treatment-indication-in-the-state-of-georgia-abstract-research-paper","Racial disparities in initiation of chemotherapy among breast cancer patients with discretionary treatment indication in the state of Georgia - Abstract - Research paper","","Study examines demographic and clinical drivers of chemotherapy initiation among estrogen receptor positive breast cancer patients in Georgia who had a discretionary indication and may face overtreatment. Using Georgia Cancer Registry data (2010–2017), logistic regression estimates odds ratios comparing non-Hispanic Black versus non-Hispanic White patients across strata of patient characteristics. Disparities appear overall, and are stronger without Oncotype DX testing and in high socioeconomic neighborhoods, while treatment becomes more equitable when guidelines are followed.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/racial-disparities-in-initiation-of-chemotherapy-among-breast-cancer-patients-with-discretionary-treatment-indication-in-the-state-of-georgia-abstract-research-paper/342800/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/racial-disparities-in-initiation-of-chemotherapy-among-breast-cancer-patients-with-discretionary-treatment-indication-in-the-state-of-georgia-abstract-research-paper/342800.png","ImageObject",300,407,{"name":92,"@type":93},"Eliana","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What population and indication does the study focus on?","Question",{"text":112,"@type":113},"The study focuses on females in Georgia diagnosed with estrogen receptor (ER) positive breast cancer who had a discretionary indication for chemotherapy from 2010 to 2017.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were chemotherapy initiation differences assessed between racial groups?",{"text":117,"@type":113},"Logistic regression estimated odds ratios and 95% confidence intervals for chemotherapy initiation overall, and compared non-Hispanic Black with non-Hispanic White women within strata defined by patient factors.",{"name":119,"@type":110,"acceptedAnswer":120},"When were racial differences in chemotherapy initiation most pronounced?",{"text":121,"@type":113},"Differences were pronounced among patients who did not receive Oncotype DX testing and among those residing in high socioeconomic status neighborhoods.",{"name":123,"@type":110,"acceptedAnswer":124},"What was observed when clinical guidelines were followed?",{"text":125,"@type":113},"More equitable chemotherapy receipt was observed among patients who received Oncotype DX testing, as well as among those diagnosed with grade 1 disease and among patients residing in rural areas.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},342800,1790125928,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":143,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":67,"update_tm":147,"read_time":148,"preview_page_count":19,"preview_urls":149},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","Breast Cancer Research and Treatment (2024) 205:609–618  \n[https://doi.org/10.1007/s10549-024-07279-w](https://doi.org/10.1007/s10549-024-07279-w)  \nRacial disparities in initiation of chemotherapy among breast cancer patients with discretionary treatment indication in the state of Georgia  \nLindsay J. Collin1 · Jade Jones2 · Rebecca Nash3 · Jeffrey M. Switchenko4 · Kevin C. Ward3 · Lauren E. McCullough3  \nReceived: 28 December 2023 / Accepted: 7 February 2024 / Published online: 22 March 2024 © The Author(s) 2024  \nAbstract  \nPurpose The majority of breast cancer patients are diagnosed with early-stage estrogen receptor (ER) positive disease. Despite effective treatments for these cancers, Black women have higher mortality than White women. We investigated demographic and clinical factors associated with receipt of chemotherapy among those with a discretionary indication who are at risk for overtreatment.  \nMethods Using Georgia Cancer Registry data, we identified females diagnosed with ER positive breast cancer who had a discretionary indication for chemotherapy (2010–2017). We used logistic regression to estimate odds ratios (ORs) and 95% confidence intervals (CIs) associating patient demographic and clinical characteristics with chemotherapy initiation overall, and comparing non-Hispanic Black (NHB) with non-Hispanic White (NHW) women within strata of patient factors. Results We identified 11,993 ER positive breast cancer patients with a discretionary indication for chemotherapy. NHB patients were more likely to initiate chemotherapy compared with NHW women (OR = 1.41, 95% CI: 1.28, 1.56) . Race differences in chemotherapy initiation were pronounced among those who did not receive Oncotype DX testing (OR = 1.47, 95% CI: 1.31, 1.65) and among those residing in high socioeconomic status neighborhoods (OR = 2.48, 95% CI: 1.70, 3.61) . However, we observed equitable chemotherapy receipt among patients who received Oncotype DX testing (OR = 0.90, 95% CI: 0.71, 1.14), were diagnosed with grade 1 disease (OR = 1.00, 95% CI: 0.74, 1.37), and those resided in rural areas (OR = 1.01, 95% CI: 0.76, 1.36) .  \nConclusion We observed racial disparities in the initiation of chemotherapy overall and by sociodemographic and clinical factors, and more equitable outcomes when clinical guidelines were followed.  \nKeywords Breast cancer · Cancer health disparities · Survivorship · Chemotherapy  \n* Lindsay J. Collin [lindsay.collin@hci.utah.edu](lindsay.collin@hci.utah.edu)  \n1 Department of Population Health Sciences, Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope Dr, Salt Lake City, UT 84112, USA  \n2 Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, USA  \n3 Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA  \n4 Department of Biostatistics, Rollins School of Public Health, Emory University, Atlanta, GA, USA  \nIntroduction  \nBreast cancer is the most commonly diagnosed cancer among women in the United States (US) and the second leading cause of cancer-specific mortality despite a high five-year relative survival of approximately 90%[1–3] . The majority of breast cancer patients present with early-stage (91%), estrogen receptor (ER) positive disease (~ 75%), and/ or no lymph node involvement (~ 65%) at diagnosis, which also contribute to the overall favorable prognosis [3–5] . Among breast cancer patients diagnosed with ER-positive disease and no lymph node involvement, chemotherapy may be considered a discretionary treatment according to the National Comprehensive Cancer Network (NCCN) clinical guidelines [6] . Chemotherapy can have severe side effects that impact quality of life [6], including neuropathy,  \ncognitive impairment (i.e.,“chemo brain”), neutropenia, infections, and other poor patient-reported outcomes. Therefore, ensuring that unnecessary chemotherapy is avoided is critical to improving quality of life for breast cancer surv","cbCaipNj3p4bgNln","https://ap.wps.com/l/cbCaipNj3p4bgNln","pdf",442479,"English","# Abstract\n## Purpose\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What population and indication does the study focus on?\",\"answer\":\"The study focuses on females in Georgia diagnosed with estrogen receptor (ER) positive breast cancer who had a discretionary indication for chemotherapy from 2010 to 2017.\"},{\"question\":\"How were chemotherapy initiation differences assessed between racial groups?\",\"answer\":\"Logistic regression estimated odds ratios and 95% confidence intervals for chemotherapy initiation overall, and compared non-Hispanic Black with non-Hispanic White women within strata defined by patient factors.\"},{\"question\":\"When were racial differences in chemotherapy initiation most pronounced?\",\"answer\":\"Differences were pronounced among patients who did not receive Oncotype DX testing and among those residing in high socioeconomic status neighborhoods.\"},{\"question\":\"What was observed when clinical guidelines were followed?\",\"answer\":\"More equitable chemotherapy receipt was observed among patients who received Oncotype DX testing, as well as among those diagnosed with grade 1 disease and among patients residing in rural areas.\"}]","Racial disparities in initiation of chemotherapy among breast cancer patients with discretionary treatment indication in the state of Georgia - Abstract - Research paper | PDF",1790048275,25,[150,154,158,162],{"page_no":8,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/be699d101307c1e817ff732dfd2165a1.webp",983,1305,{"page_no":14,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/31196943bc990da35b58e4171cb07d73.webp",982,1304,{"page_no":81,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/92110c1bc17934e747a4ddb4e95ef387.webp",981,1303,{"page_no":19,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f10e88a796a685a34736eb507bbfe2e7.webp",980,1301]